- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Gene-based Advanced Therapy Medical Product market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Gene-based Advanced Therapy Medical Product market. Detailed analysis of key players, along with key growth strategies adopted by Gene-based Advanced Therapy Medical Product industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
bluebird bio
Human Stem Cells Institute
Alnylam Pharmaceuticals
Spark Therapeutics
Orchard Therapeutics
Biogen
Sunway Biotech
Gilead Sciences
Novartis
Sarepta Therapeutics
Akcea Therapeutics
SIBIONO
AnGes
Amgen
By Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
By End-User:
Neurological Diseases
Cancer
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene-based Advanced Therapy Medical Product Market
-
1.3 Market Segment by Type
-
1.3.1 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Viral Gene Delivery System from 2016 to 2027
-
1.3.2 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Non-viral Gene Delivery System from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Neurological Diseases from 2016 to 2027
-
1.4.2 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.3 USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Gene-based Advanced Therapy Medical Product Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene-based Advanced Therapy Medical Product by Major Types
-
3.4.1 Market Size and Growth Rate of Viral Gene Delivery System
-
3.4.2 Market Size and Growth Rate of Non-viral Gene Delivery System
4 Segmentation of Gene-based Advanced Therapy Medical Product Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene-based Advanced Therapy Medical Product by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Neurological Diseases
-
4.4.2 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Cancer
-
4.4.3 Market Size and Growth Rate of Gene-based Advanced Therapy Medical Product in Other
5 Market Analysis by Regions
-
5.1 USA Gene-based Advanced Therapy Medical Product Production Analysis by Regions
-
5.2 USA Gene-based Advanced Therapy Medical Product Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis
-
6.1 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types
-
6.2 West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users
7 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis
-
7.1 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types
-
7.2 South USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users
8 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis
-
8.1 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types
-
8.2 Middle West USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users
9 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis
-
9.1 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major Types
-
9.2 Northeast USA Gene-based Advanced Therapy Medical Product Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 bluebird bio
-
10.1.1 bluebird bio Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Human Stem Cells Institute
-
10.2.1 Human Stem Cells Institute Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Alnylam Pharmaceuticals
-
10.3.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Spark Therapeutics
-
10.4.1 Spark Therapeutics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Orchard Therapeutics
-
10.5.1 Orchard Therapeutics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Biogen
-
10.6.1 Biogen Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Sunway Biotech
-
10.7.1 Sunway Biotech Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Gilead Sciences
-
10.8.1 Gilead Sciences Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis
-
10.9.1 Novartis Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Sarepta Therapeutics
-
10.10.1 Sarepta Therapeutics Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Akcea Therapeutics
-
10.11.1 Akcea Therapeutics Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 SIBIONO
-
10.12.1 SIBIONO Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AnGes
-
10.13.1 AnGes Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Amgen
-
10.14.1 Amgen Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Viral Gene Delivery System from 2016 to 2027
-
Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Non-viral Gene Delivery System from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Neurological Diseases from 2016 to 2027
-
Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA Gene-based Advanced Therapy Medical Product Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Gene-based Advanced Therapy Medical Product Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Gene-based Advanced Therapy Medical Product
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene-based Advanced Therapy Medical Product by Different Types from 2016 to 2027
-
Table Consumption Share of Gene-based Advanced Therapy Medical Product by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Viral Gene Delivery System
-
Figure Market Size and Growth Rate of Non-viral Gene Delivery System
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Gene-based Advanced Therapy Medical Product by Different End-Users from 2016 to 2027
-
Table Consumption Share of Gene-based Advanced Therapy Medical Product by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Neurological Diseases
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Other
-
Table USA Gene-based Advanced Therapy Medical Product Production by Regions
-
Table USA Gene-based Advanced Therapy Medical Product Production Share by Regions
-
Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2016
-
Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2021
-
Figure USA Gene-based Advanced Therapy Medical Product Production Share by Regions in 2027
-
Table USA Gene-based Advanced Therapy Medical Product Consumption by Regions
-
Table USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions
-
Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2016
-
Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2021
-
Figure USA Gene-based Advanced Therapy Medical Product Consumption Share by Regions in 2027
-
Table West USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027
-
Table West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027
-
Table West USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027
-
Table West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021
-
Figure West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027
-
Table South USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027
-
Table South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027
-
Table South USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027
-
Table South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021
-
Figure South USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027
-
Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027
-
Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027
-
Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021
-
Figure Middle West USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027
-
Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption by Types from 2016 to 2027
-
Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2016
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2021
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by Types in 2027
-
Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2016
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2021
-
Figure Northeast USA Gene-based Advanced Therapy Medical Product Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of bluebird bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of bluebird bio
-
Figure Sales and Growth Rate Analysis of bluebird bio
-
Figure Revenue and Market Share Analysis of bluebird bio
-
Table Product and Service Introduction of bluebird bio
-
Table Company Profile and Development Status of Human Stem Cells Institute
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Human Stem Cells Institute
-
Figure Sales and Growth Rate Analysis of Human Stem Cells Institute
-
Figure Revenue and Market Share Analysis of Human Stem Cells Institute
-
Table Product and Service Introduction of Human Stem Cells Institute
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
Table Company Profile and Development Status of Spark Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
-
Figure Sales and Growth Rate Analysis of Spark Therapeutics
-
Figure Revenue and Market Share Analysis of Spark Therapeutics
-
Table Product and Service Introduction of Spark Therapeutics
-
Table Company Profile and Development Status of Orchard Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orchard Therapeutics
-
Figure Sales and Growth Rate Analysis of Orchard Therapeutics
-
Figure Revenue and Market Share Analysis of Orchard Therapeutics
-
Table Product and Service Introduction of Orchard Therapeutics
-
Table Company Profile and Development Status of Biogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
-
Figure Sales and Growth Rate Analysis of Biogen
-
Figure Revenue and Market Share Analysis of Biogen
-
Table Product and Service Introduction of Biogen
-
Table Company Profile and Development Status of Sunway Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sunway Biotech
-
Figure Sales and Growth Rate Analysis of Sunway Biotech
-
Figure Revenue and Market Share Analysis of Sunway Biotech
-
Table Product and Service Introduction of Sunway Biotech
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Sarepta Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sarepta Therapeutics
-
Figure Sales and Growth Rate Analysis of Sarepta Therapeutics
-
Figure Revenue and Market Share Analysis of Sarepta Therapeutics
-
Table Product and Service Introduction of Sarepta Therapeutics
-
Table Company Profile and Development Status of Akcea Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Akcea Therapeutics
-
Figure Sales and Growth Rate Analysis of Akcea Therapeutics
-
Figure Revenue and Market Share Analysis of Akcea Therapeutics
-
Table Product and Service Introduction of Akcea Therapeutics
-
Table Company Profile and Development Status of SIBIONO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SIBIONO
-
Figure Sales and Growth Rate Analysis of SIBIONO
-
Figure Revenue and Market Share Analysis of SIBIONO
-
Table Product and Service Introduction of SIBIONO
-
Table Company Profile and Development Status of AnGes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AnGes
-
Figure Sales and Growth Rate Analysis of AnGes
-
Figure Revenue and Market Share Analysis of AnGes
-
Table Product and Service Introduction of AnGes
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-